TriStar Health Partners

  • Home
  • About
    • TriStar
    • Team
  • News
  • Investment Strategy
    • Investment Strategy
    • Economic Development Fund – TN Investco
  • Portfolio
  • Contact

Novel Hemodialysis Access System Demonstrates High Suitability For Dialysis In Clinical Trial

February 3, 2016 By tstventures2015

TVA Medical, Inc., announced primary endpoint data from a prospective, multicenter clinical study evaluating the everlinQ™ endoAVF System. This novel medical technology creates an arteriovenous (AV) fistula for hemodialysis access in people with end-state kidney disease (ESKD) using an endovascular approach in vessels not traditionally used during surgery. (Read More)

Filed Under: News

Our Portfolio


VIEW MORE

Subscribe to News & Events

Contact Us

Thank you for your interest in TriStar Health Partners. If you have questions or need further information, please contact us!

TriStar Health Partners

3322 West End Ave, Suite 1100 | Nashville, TN 37203
615.515-9880

Copyright © 2023 TriStar Technology Ventures. All rights reserved (CC-licensed photos excepted).